TY - JOUR AU - Thome, Trace AU - Kumar, Ravi A. AU - Burke, Sarah K. AU - Khattri, Ram B. AU - Salyers, Zachary R. AU - Kelley, Rachel C. AU - Coleman, Madeline D. AU - Christou, Demetra D. AU - Hepple, Russell T. AU - Scali, Salvatore T. AU - Ferreira, Leonardo F. AU - Ryan, Terence E. T1 - Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease PY - 2021/01/11/ AB - Chronic kidney disease (CKD) causes progressive skeletal myopathy involving atrophy, weakness, and fatigue. Mitochondria have been thought to contribute to skeletal myopathy; however, the molecular mechanisms underlying muscle metabolism changes in CKD are unknown. We employed a comprehensive mitochondrial phenotyping platform to elucidate the mechanisms of skeletal muscle mitochondrial impairment in mice with adenine-induced CKD. CKD mice displayed significant reductions in mitochondrial oxidative phosphorylation (OXPHOS), which was strongly correlated with glomerular filtration rate, suggesting a link between kidney function and muscle mitochondrial health. Biochemical assays uncovered that OXPHOS dysfunction was driven by reduced activity of matrix dehydrogenases. Untargeted metabolomics analyses in skeletal muscle revealed a distinct metabolite profile in CKD muscle including accumulation of uremic toxins that strongly associated with the degree of mitochondrial impairment. Additional muscle phenotyping found CKD mice experienced muscle atrophy and increased muscle protein degradation, but only male CKD mice had lower maximal contractile force. CKD mice had morphological changes indicative of destabilization in the neuromuscular junction. This study provides the first comprehensive evaluation of mitochondrial health in murine CKD muscle to our knowledge and uncovers several unknown uremic metabolites that strongly associate with the degree of mitochondrial impairment. JF - JCI Insight JA - JCI Insight SN - 2379-3708 DO - 10.1172/jci.insight.139826 VL - 6 IS - 1 UR - https://doi.org/10.1172/jci.insight.139826 PB - The American Society for Clinical Investigation ER -